Dingxie Liu

High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/akt pathway in thyroid tumors.

Wei Wang, Bingyin Shi, Peng Hou, 2007, The Journal of clinical endocrinology and metabolism.

Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin.

Peng Hou, Guojun Wu, P. Hou, 2009, Cancer research.